Evidence map›Paper›PMID 37270680›Full record

ArticleAnnals of Saudi medicine

Impact of non-pharmaceutical interventions on circulating respiratory viruses during the COVID-19 pandemic in Turkey.

Füsun Kırca, Sibel Aydoğan, Aysegul Gozalan, Ezgi Güler, Ayşegül Zehra Uyan Erten, Ayşe Sena Özşen Uygur, Alper Doğan, Bedia Dinc

Open access · diamondAbstract read
In one paragraph

Article in Annals of Saudi medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Füsun KırcaFrom the Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.ORCID 0000-0003-0959-9091
Sibel AydoğanFrom the Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.
Aysegul GozalanFrom the Department of Medical Microbiology, Alanya Alaaddin Keykubat University, Antalya Turkey.
Ezgi GülerFrom the Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.
Ayşegül Zehra Uyan ErtenFrom the Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.
Ayşe Sena Özşen UygurFrom the Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.
Alper DoğanFrom the Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.
Bedia DincFrom the Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.
Bilkent University · TRAlanya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-pharmaceutical interventions (NPIs) applied to limit the SARS-CoV-2 pandemic also affect the circulation and seasonal characteristics of other respiratory viruses.

objectivesAssess the impact of NPIs on the spread and seasonal characteristics of non-SARS-CoV-2 respiratory viruses and examine viral respiratory co-infections.

designRetrospective cohort

settingSingle center in Turkey. PATIENTS AND

methodsSyndromic multiplex viral polymerase chain reaction (mPCR) panel results of patients admitted to the Ankara Bilkent City Hospital with symptoms of acute respiratory tract infection between April 1, 2020 and October 30, 2022 were evaluated. Two study periods before and after 1 July 2021, when the restrictions were discontinued, were statistically analyzed and compared to determine the effect of NPIs on circulating respiratory viruses.

main outcome measuresPrevalence of respiratory viruses as determined by syndromic mPCR panel. SAMPLE SIZE: 11300 patient samples were evaluated.

resultsAt least one respiratory tract virus was detected in 6250 (55.3%) patients. Of these, at least one respiratory virus was detected in 5% in the first period (between April 1, 2020 and June 30, 2021, when NPIs were applied), and in 95% in the second period (between July 1, 2021 and October 30, 2022, when NPIs were relaxed). After the removal of NPIs, there was a statistically significant increase in hRV/EV, RSV-A/B, Flu A/H3, hBoV, hMPV, PIV-1, PIV-4, hCoV-OC43, PIV-2 and hCoV-NL63 (

conclusionsNPIs resulted in a dramatic decrease in the prevalence of respiratory viruses and notable disruption of seasonal characteristics. LIMITATIONS: Single-center study and retrospective. CONFLICT OF INTEREST: None.

Indexed as

COVID-19Respiratory Tract InfectionsVirus DiseasesVirusesHumansPandemicsRetrospective StudiesSARS-CoV-2Turkey

Identifiers

PMID37270680
PMCPMC10317495
OpenAlexW4379278572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.